Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1970 Oct 3;4(5726):18-21.
doi: 10.1136/bmj.4.5726.18.

Correlation of subjective side effects with plasma concentrations of nortriptyline

Correlation of subjective side effects with plasma concentrations of nortriptyline

M Asberg et al. Br Med J. .

Abstract

Plasma levels of tricyclic antidepressant drugs vary considerably between individuals receiving the same amount of drug. The bearing of this variation on the occurrence of subjective side effects was investigated in 40 psychiatric inpatients with depressive disorders. Plasma levels were determined before and during four weeks of treatment with nortriptyline 50 mg. three times a day and patients were rated for subjective side effects, the assessors being unaware of the plasma levels of the drug.Plasma levels varied widely between individual patients, but in any given patient the plasma level tended to be constant over a period of time. The side effects of nortriptyline diminished significantly with time and were in most cases absent during the fourth week of treatment. There was a significant positive correlation between plasma level of nortriptyline and subjective side effects.The steady-state plasma level of a drug which is metabolized is usually a more important determinant for its effect than dosage, since it reflects the amount of drug available for biological action. Very high plasma levels of nortriptyline should presumably be avoided, since there is no evidence that they are needed for therapeutic effect and they are potentially harmful.

PubMed Disclaimer

References

    1. Biochem Pharmacol. 1969 Sep;18(9):2135-43 - PubMed
    1. Br Med J. 1969 Dec 27;4(5686):764-8 - PubMed
    1. Br J Med Psychol. 1959;32(1):50-5 - PubMed
    1. Br J Psychiatry. 1963 Mar;109:251-8 - PubMed
    1. Ann Intern Med. 1964 Feb;60:255-65 - PubMed

LinkOut - more resources